Postdoctoral fellowships

Awarded fellowships

Edition 2020-2021

Melody Atkins

Institut du Fer à Moulin. Paris, France

Primary cilium-dependent cortical interneuron migration in Down Syndrome mouse models

Financing: Fondation Lejeune  

Daniella Balduino Victorino

Institut du Cerveau et de la Moelle Epinière. Paris, France

Elucidating the effects of age-related and tissue-specific modulation of DYRK1A expression on Alzheimer’s disease-like pathology in mice

Financing: Fondation Lejeune  

René Crans

Centre for Genomic Regulation. Barcelona, Spain

Stratifying Cognitive Improvements to Reveal the Effect of Allelic Diversity in Trisomy 21

Financing: Fondation Lejeune

Nakisa Malakooti

Monash University. Clayton, Australia

Understanding how gene interactions in Down syndrome impacts cognitive decline; structure to function relationships in brains

Financing: Fondation Lejeune

Nunzia Mollo

University of Naples Federico II. Naples, Italy

Defects in mitophagy and mitochondrial activity as key determinants of Alzheimer’s disease in Down Syndrome: novel therapeutic strategies

Financing: Fondation Lejeune  

Annalisa Savardi

Fondazione Istituto Italiano di Tecnologia. Genova, Italy

Early NKCC1 Inhibition to treat epilepsy and hyperactivity in Down syndrome

Financing: Fondation Lejeune  

Birger Tielemans

KU Leuven. Leuven, Belgium

Cardiopulmonary-vascular disorders in Down syndrome research: a long-overlooked issue

Financing: Fondation Lejeune

Edition 2019-2020

Javier Aguado Perez

University of Queensland. Brisbane, Australia

Elucidating the genetic drivers of accelerated cellular ageing in Down syndrome

Financing: Fondation Lejeune 

Carlos Aya-Bonilla

University of Western Australia. Perth, Australia

Down syndrome-Acute lymphoblastic leukaemia (DS-ALL): A model to unravel the molecular mechanisms underlying treatment-resistance in paediatric leukaemia »

Co-financing: Fondation Sisley-D’Ornano and Fondation Lejeune        

Aoife Murray

Blizzard Institute. Queen Mary University of London. London, United Kingdom

Assessment of specific biological features of trisomy 21 neurons, affecting cell-cell transmission of Alzheimer’s pathology using cerebral organoids

Financing: Fondation Lejeune 

Javier Zorrilla De San Martin

Institut du Cerveau et de la Moelle Epinière. Paris, France

Role of PFC SST+ interneurons on emotional state recognition in a mouse model of Down syndrome

Financing: Fondation Lejeune 

Edition 2018-2019

Marta Fructuoso Castellar

Institut du Cerveau et de la Moelle Epinière. Paris, France

Uncovering the signaling pathways to neurodegeneration of the locus coerulus, and cognitive impairments in Down syndrome

Co-financing: Fondation Sisley-D’Ornano and Fondation Lejeune        

Elsa Pittaras

Stanford University. Stanford, United States

Usp16 as a new therapeutic target in Alzheimer disease and Down syndrome

Financing: Fondation Lejeune 

Edition 2017-2018

Maria Victoria Hinckelmann Rivas

Institut de Génétique et de Biologie Moléculaire et Cellulaire. Illkirch, France

Role of DYRK1A in GABAergic inhibitory neurons development, impact on the excitatory/inhibitory balance in diseases with intellectual disabilities

Co-financing: Fondation Sisley-D’Ornano and Fondation Lejeune      

  

Florencia Iulita

Hospital de la Santa Creu i Sant Pau. Barcelona, Spain

Discovery of novel biomarkers signaling NGF metabolic dysfunction and early AD-dementia in Down syndrome

Financing: Fondation Lejeune 

Edition 2016-2017

Ioannis Sotiropoulos

Life and health science research institute. University of Minho. Braga, Portugal

Tau therapeutics in Down syndrome & Alzheimer’s disease brain pathologies

Co-financing: Fondation Sisley-D’Ornano and Fondation Lejeune